EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have been assigned an average recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have updated their coverage on […]
More Stories
Stryker Co. (NYSE:SYK) Shares Sold by Meeder Advisory Services Inc.
Meeder Advisory Services Inc. cut its stake in Stryker Co. (NYSE:SYK – Free Report) by 3.4% in the third quarter,...
Meeder Advisory Services Inc. Purchases 42 Shares of S&P Global Inc. (NYSE:SPGI)
Meeder Advisory Services Inc. raised its stake in shares of S&P Global Inc. (NYSE:SPGI – Free Report) by 0.8% during...
Investment Analysts’ Recent Ratings Updates for Allogene Therapeutics (ALLO)
Allogene Therapeutics (NASDAQ: ALLO) has recently received a number of price target changes and ratings updates: 11/14/2024 – Allogene Therapeutics...
Cisco Reports 4th Consecutive Revenue Decline, Looks to AI for Growth Revival
By Panos Mourdoukoutas Cisco Systems is well positioned to capitalize on the opportunity in artificial intelligence (AI) to revive sales...
Wirtual (WIRTUAL) Trading Up 83.8% Over Last Week
Wirtual (WIRTUAL) traded 4.2% lower against the U.S. dollar during the 1 day period ending at 12:00 PM E.T. on...
Wanchain 1-Day Volume Hits $2.35 Million (WAN)
Wanchain (WAN) traded 0.3% lower against the US dollar during the one day period ending at 12:00 PM ET on...